Home › Mantle Cell Lymphoma › Massachusetts › Boston

Pag-aaral pangklinika para sa Mantle Cell Lymphoma sa Boston, MA

Isang pag-aaral para sa Mantle Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05006716

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06697184

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Nagre-recruitPhase 3

Dana Farber Cancer Institute Longwood Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Nagre-recruitPhase 1/2

Research Site, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06564038

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 16, 2026 · NCT06026319

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

Nagre-recruitPhase 2

Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT06854003

Study of SGR-1505 in Mature B-Cell Neoplasms

Nagre-recruitPhase 1

Beth Israel Deaconess Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

CONFIRM: Magnetic Resonance Guided Radiation Therapy

Nagre-recruit

Brigham & Women's Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 9, 2026 · NCT04368702

Avo In R/R And Previously Untreated MCL

Nagre-recruitPhase 1/2

Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT04855695

Pag-aaral para sa Mantle Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.